1 research outputs found
Liquid Chromatography–Tandem Mass Spectrometry Determination and Pharmacokinetic Analysis of Amentoflavone and Its Conjugated Metabolites in Rats
Amentoflavone
(AMF) is a biflavone found in many herbal dietary
supplements. To investigate the pharmacokinetic profile of AMF in
rats, a sensitive, simple, and accurate liquid chromatography–tandem
mass spectrometry (LC–MS/MS) method was developed and used
to monitor AMF and its conjugated metabolites in plasma. AMF was administered
to rats by oral gavage (po), or by intravenous (iv) or intraperitoneal
(ip) injection. Plasma samples (with apiolin as an internal standard)
were liquid/liquid extracted after hydrolysis with β-glucuronidase/sulfatase
in vitro. Following chromatographic separation on a C18 column with
a methanol:water:formic acid (70:30:0.1, v/v/v) mobile phase, AMF
and internal standard were determined by electrospray ionization in
negative ion mode and their precursor–product ion pairs (<i>m</i>/<i>z</i> 537.1 → 374.9 and <i>m</i>/<i>z</i> 269.2 → 224.9, respectively) were used
for measurement. This bioanalytical method was fully validated and
showed good linearity (<i>r</i><sup>2</sup> > 0.99),
wide
dynamic range (0.93–930 nmol/L), and favorable accuracy and
precision. After iv or ip AMF (10 mg/kg) injection, 73.2% ± 6.29%
and 70.2% ± 5.18% of the total AMF detected in plasma was present
as conjugated metabolites. Furthermore, AMF and AMF conjugates showed
similar time courses with no significant differences in the time to
reach the maximum plasma concentration (<i>t</i><sub>max</sub>) and terminal half-life (<i>t</i><sub>1/2</sub>) (<i>p</i> > 0.05). Following po AMF administration (300 mg/kg),
90.7% ± 8.3% of the total AMF was circulating as conjugated metabolites.
When compared with iv administration (with dose correction), the bioavailability
of po AMF was very low (0.04% ± 0.01% for free AMF; 0.16% ±
0.04% for conjugated AMF). Collectively, these data provided a preliminary
pharmacokinetic profile for AMF that should inform further evaluations
of its biological efficacy and preclinical development